Ecnoglutide vs Tirzepatide

Ecnoglutide is an experimental GLP-1 drug still in development, not yet approved for any conditions. In contrast, tirzepatide (sold as Mounjaro or Zepbound) is an FDA-approved treatment for type 2 diabetes, obesity, and obstructive sleep apnea. While ecnoglutide targets only the GLP-1 receptor, tirzepatide works on both GLP-1 and GIP receptors. Tirzepatide is available now as an injectable medication from Eli Lilly.

AI summary of the sources below.